News

Tirzepatide is a weight loss drug for adults with obesity or with overweight who also have weight-related medical problems, as Zepbound in the US and Mounjaro in some countries outside of the US ...
Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for pharmaceutical products — without naming the friend he was talking about.
Both the Mounjaro and Wegovy jabs used in the trial were found to be effective treatments for patients with obesity, but one ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Houston-based Empower Pharmacy has repeatedly been admonished by the FDA for failing to follow federal rules that ensure drug ...
Many economists expect muted U.S. economic growth in the coming quarters, and the first quarter's negative GDP growth makes a mild recession a real possibility. It may become difficult for ...
Gov. Josh Stein is scheduled to attend a press briefing with the chief executive of a biopharma company on Monday. People familiar with the matter tell WRAL that a company is considering an investment ...
Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight-loss medicines that make people feel fuller for longer and therefore less hungry.
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...